Biophilia Tracker's New Matter Apparatus to Study Crohn's Disease

Biophilia Tracker's New Matter Apparatus to Study Crohn's Disease

Crohn's disease - is a chronic relapsing disease of the gastrointestinal tract of unknown etiology, characterized by a transmural segmental distribution of inflammatory processes, with the development of local and systemic complications. The problem of this disease continues to attract researchers' attention due to the increasing incidence over the past 3 years. The increasing incidence of the disease, the predominant impact of young able-bodied people, the severe complications leading to early physical disability, all these aspects make this problem not only a medical problem but also a social one. All of this speaks to the urgency of delving into this disease. The location and extent of intestinal pathological processes, disease activity, and presence of complications are important in the definition of medical strategies for Crohn's disease. Crohn's disease develops in waves, alternating periods of exacerbation and remission. Information on the degree of activity of the inflammatory process can help to adequately treat these patients. In Crohn's disease, it is difficult to determine the degree of process activity because the patient's condition depends not only on the manifestation of the intestinal process, but also on the presence of accompanying complications such as infiltration, abscess, fistula, stricture, or even the patient's mental condition.

To determine the level of Crohn's disease activity, the Best index was used. In addition to Best's index, there are conditional biomarkers of inflammatory process performance, such as C-reactive protein, erythrocyte sedimentation rate, platelet count, fibrinogen, as well as endoscopic and contrastive study methods. However, instrumental survey methods lack the pitfalls associated with the risk of disease progression during preparation for a given examination and irradiation. The NLS-diagnostic method has no such flaws.

Research shows a highly informative approach to treating intestinal tumor disease. Based on our data, the possibility of using NLS imaging to diagnose process location, reveal complications, and define process activity in Crohn's disease has never been investigated.

T. Kuznetsova et al. completed the first NLS study of the gut. In 2000, to develop an NLS differential diagnosis of biliary tract lesions in the distal large bowel.

Therefore, the Biophilia Tracker investigates the real possibilities of methods in the diagnosis and differential diagnosis of Crohn's disease in the large and small intestines, and applies new technologies of modern diagnostic biomass devices.